To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Incyte by 162 shares, the number of shares held increased 0.12% compared to the previous period and now represents 1.12% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Veeva by 48 shares, the number of shares held increased 0.12% compared to the previous period and now represents 0.73% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 2,531 shares, the number of shares held increased 0.13% compared to the previous period and now represents 3.17% of the total position.
      31
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 3,271 shares, the number of shares held decreased 1.43% compared to the previous period and now represents 4.54% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Tempus AI by 34,646 shares, the number of shares held increased 2.15% compared to the previous period and now represents 9.02% of the total position.
      26Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 31 shares, the number of shares held increased 0.13% compared to the previous period and now represents 0.94% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 14,519 shares, the number of shares held increased 0.13% compared to the previous period and now represents 4.29% of the total position.
      296Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 3,919 shares, the number of shares held increased 0.13% compared to the previous period and now represents 4.86% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 1,902 shares, the number of shares held increased 0.13% compared to the previous period and now represents 2.25% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in CareDx by 2,540 shares, the number of shares held increased 0.13% compared to the previous period and now represents 3.41% of the total position.
      1Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed